A potent 5-hydroxytryptamine receptor (5-HT2A) antagonist, DV-7028, delays arterial thrombosis development in rats.
about
Endobrevin/VAMP-8-dependent dense granule release mediates thrombus formation in vivoOxytocic activity of thrombin: modulation of thrombin-induced gravid rat myometrial contractions by 5-hydroxytryptamine receptor antagonists.Systems pharmacology analysis of synergy of TCM: an example using saffron formula.
P2860
A potent 5-hydroxytryptamine receptor (5-HT2A) antagonist, DV-7028, delays arterial thrombosis development in rats.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
A potent 5-hydroxytryptamine r ...... hrombosis development in rats.
@en
A potent 5-hydroxytryptamine r ...... hrombosis development in rats.
@nl
type
label
A potent 5-hydroxytryptamine r ...... hrombosis development in rats.
@en
A potent 5-hydroxytryptamine r ...... hrombosis development in rats.
@nl
prefLabel
A potent 5-hydroxytryptamine r ...... hrombosis development in rats.
@en
A potent 5-hydroxytryptamine r ...... hrombosis development in rats.
@nl
P2093
P1433
P1476
A potent 5-hydroxytryptamine r ...... thrombosis development in rats
@en
P2093
P304
P356
10.1016/S0049-3848(98)00037-1
P577
1998-06-01T00:00:00Z